A recent health crisis, exemplified by the situation involving Vaimse, has exposed a significant and negative impact extending from the individual level to the national structure. This situation has amplified discussions regarding supportive therapies for mental health, an area increasingly supported by promising research findings, leading some to speak of a potential psychiatric renaissance. Oliver Berg, a board member of the TAIP Foundation, provided clarification on these complex topics. He addressed what psychopharmaceuticals entail, detailing their application in therapy, and critically assessing their potential role within the Estonian healthcare system. The discussion centers on the shift in focus toward therapeutic support mechanisms. According to Berg, the evidence base for modern mental health treatment is expanding, suggesting that interventions beyond traditional models are proving effective. He elaborated on the mechanisms of these medications and therapies, aiming to demystify the process for the public and healthcare providers alike. Berg’s explanation serves to guide the conversation about integrating these advanced treatments into mainstream care. The goal, as presented, is to evaluate whether the efficacy demonstrated in research warrants a broader adoption within national health policy. By detailing the scope and utility of psychopharmaceuticals, Oliver Berg aims to foster a more informed dialogue regarding the future standards of mental healthcare provision in Estonia. Topics: #oliver #berg #vaimse Post navigation MAARJA-LIISA KAPAUN⟩Me ei tohi teha kodanikuühiskonnast projektimasinat ANNA-KAISA OIDERMAA⟩Kuidas inimene üksilduse lõksust välja aidata?